Saltar al contenido
Merck
  • Is Leber hereditary optic neuropathy treatable? Encouraging results with idebenone in both prospective and retrospective trials and an illustrative case.

Is Leber hereditary optic neuropathy treatable? Encouraging results with idebenone in both prospective and retrospective trials and an illustrative case.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society (2012-01-25)
Esfandiar J Sabet-Peyman, Khizer R Khaderi, Alfredo A Sadun
RESUMEN

A 31-year-old woman developed subacute bilateral visual loss over a 2-week period. Two months later, the diagnosis of Leber hereditary optic neuropathy (LHON) 11778/ND4 was established and the patient was treated with 900 mg of idebenone daily. Over the ensuing 9 months, visual acuity improved from 20/200 to 20/25 in each eye with near-total resolution in visual field abnormalities. Our case report is in agreement with 2 large published series of patients with LHON treated with idebenone, raising hope for treatment of this visually devastating mitochondrial disorder.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Idevenone, ≥98% (HPLC)
Supelco
Idevenone, analytical standard